The global market for Renal Biomarkers was estimated to be worth US$ 1168.6 million in 2023 and is forecast to a readjusted size of US$ 1643.2 million by 2030 with a CAGR of 4.9% during the forecast period 2024-2030

Renal Biomarkers - Market

Renal biomarkers help diagnose or identify the patients at risk of developing kidney diseases, by measuring their blood or urine levels. They are commonly released in acute or chronic kidney injuries, which are characterized by the rapid or gradual loss of kidney function resulting into serous clinical implications.

The major factors fuelling the global renal biomarkers market are increased incidence of kidney diseases, large geriatric population and increasing prevalence of multiple co-morbidities.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Renal Biomarkers, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Renal Biomarkers by region & country, by Type, and by Application.

The Renal Biomarkers market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Renal Biomarkers.

Market Segmentation

Scope of Renal Biomarkers - Market Report

Report Metric	Details
Report Name	Renal Biomarkers - Market
Forecasted market size in 2030	US$ 1643.2 million
CAGR	4.9%
Forecasted years	2024 - 2030
Segment by Type:	Enzyme Linked Immunosorbent Assay (ELISA) Enzymatic Assay Turbidimetric Immunoassay Others
Segment by Application	Diagnosis and Disease Progression Monitoring Research Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott Diagnostics, F. Hoffmann-La Roche, Beckman Coulter, Siemens Healthcare Diagnostics, Thermo Fisher Scientific, Astute Medical, BioMerieux SA, Randox Laboratories, Diagnostics A/S, Sphingo Tec GmbH, Eli Lilly and Company, Novartis AG, Gentian Diagnostic, Proteomics International, BioPorto
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Renal Biomarkers manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Renal Biomarkers in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Renal Biomarkers in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Renal Biomarkers - Market size in 2030?

Ans: The Renal Biomarkers - Market size in 2030 will be US$ 1643.2 million.

Who are the main players in the Renal Biomarkers - Market report?

Ans: The main players in the Renal Biomarkers - Market are Abbott Diagnostics, F. Hoffmann-La Roche, Beckman Coulter, Siemens Healthcare Diagnostics, Thermo Fisher Scientific, Astute Medical, BioMerieux SA, Randox Laboratories, Diagnostics A/S, Sphingo Tec GmbH, Eli Lilly and Company, Novartis AG, Gentian Diagnostic, Proteomics International, BioPorto

What are the Application segmentation covered in the Renal Biomarkers - Market report?

Ans: The Applications covered in the Renal Biomarkers - Market report are Diagnosis and Disease Progression Monitoring, Research, Others

What are the Type segmentation covered in the Renal Biomarkers - Market report?

Ans: The Types covered in the Renal Biomarkers - Market report are Enzyme Linked Immunosorbent Assay (ELISA), Enzymatic Assay, Turbidimetric Immunoassay, Others

1 Market Overview

1.1 Renal Biomarkers Product Introduction

1.2 Global Renal Biomarkers Market Size Forecast

1.3 Renal Biomarkers Market Trends & Drivers

1.3.1 Renal Biomarkers Industry Trends

1.3.2 Renal Biomarkers Market Drivers & Opportunity

1.3.3 Renal Biomarkers Market Challenges

1.3.4 Renal Biomarkers Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Renal Biomarkers Players Revenue Ranking (2023)

2.2 Global Renal Biomarkers Revenue by Company (2019-2024)

2.3 Key Companies Renal Biomarkers Manufacturing Base Distribution and Headquarters

2.4 Key Companies Renal Biomarkers Product Offered

2.5 Key Companies Time to Begin Mass Production of Renal Biomarkers

2.6 Renal Biomarkers Market Competitive Analysis

2.6.1 Renal Biomarkers Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Renal Biomarkers Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Renal Biomarkers as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Enzyme Linked Immunosorbent Assay (ELISA)

3.1.2 Enzymatic Assay

3.1.3 Turbidimetric Immunoassay

3.1.4 Others

3.2 Global Renal Biomarkers Sales Value by Type

3.2.1 Global Renal Biomarkers Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Renal Biomarkers Sales Value, by Type (2019-2030)

3.2.3 Global Renal Biomarkers Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Diagnosis and Disease Progression Monitoring

4.1.2 Research

4.1.3 Others

4.2 Global Renal Biomarkers Sales Value by Application

4.2.1 Global Renal Biomarkers Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Renal Biomarkers Sales Value, by Application (2019-2030)

4.2.3 Global Renal Biomarkers Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Renal Biomarkers Sales Value by Region

5.1.1 Global Renal Biomarkers Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Renal Biomarkers Sales Value by Region (2019-2024)

5.1.3 Global Renal Biomarkers Sales Value by Region (2025-2030)

5.1.4 Global Renal Biomarkers Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Renal Biomarkers Sales Value, 2019-2030

5.2.2 North America Renal Biomarkers Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Renal Biomarkers Sales Value, 2019-2030

5.3.2 Europe Renal Biomarkers Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Renal Biomarkers Sales Value, 2019-2030

5.4.2 Asia Pacific Renal Biomarkers Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America Renal Biomarkers Sales Value, 2019-2030

5.5.2 South America Renal Biomarkers Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Renal Biomarkers Sales Value, 2019-2030

5.6.2 Middle East & Africa Renal Biomarkers Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Renal Biomarkers Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Renal Biomarkers Sales Value

6.3 United States

6.3.1 United States Renal Biomarkers Sales Value, 2019-2030

6.3.2 United States Renal Biomarkers Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Renal Biomarkers Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Renal Biomarkers Sales Value, 2019-2030

6.4.2 Europe Renal Biomarkers Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Renal Biomarkers Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Renal Biomarkers Sales Value, 2019-2030

6.5.2 China Renal Biomarkers Sales Value by Type (%), 2023 VS 2030

6.5.3 China Renal Biomarkers Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Renal Biomarkers Sales Value, 2019-2030

6.6.2 Japan Renal Biomarkers Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Renal Biomarkers Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Renal Biomarkers Sales Value, 2019-2030

6.7.2 South Korea Renal Biomarkers Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Renal Biomarkers Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Renal Biomarkers Sales Value, 2019-2030

6.8.2 Southeast Asia Renal Biomarkers Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Renal Biomarkers Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Renal Biomarkers Sales Value, 2019-2030

6.9.2 India Renal Biomarkers Sales Value by Type (%), 2023 VS 2030

6.9.3 India Renal Biomarkers Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Abbott Diagnostics

7.1.1 Abbott Diagnostics Profile

7.1.2 Abbott Diagnostics Main Business

7.1.3 Abbott Diagnostics Renal Biomarkers Products, Services and Solutions

7.1.4 Abbott Diagnostics Renal Biomarkers Revenue (US$ Million) & (2019-2024)

7.1.5 Abbott Diagnostics Recent Developments

7.2 F. Hoffmann-La Roche

7.2.1 F. Hoffmann-La Roche Profile

7.2.2 F. Hoffmann-La Roche Main Business

7.2.3 F. Hoffmann-La Roche Renal Biomarkers Products, Services and Solutions

7.2.4 F. Hoffmann-La Roche Renal Biomarkers Revenue (US$ Million) & (2019-2024)

7.2.5 F. Hoffmann-La Roche Recent Developments

7.3 Beckman Coulter

7.3.1 Beckman Coulter Profile

7.3.2 Beckman Coulter Main Business

7.3.3 Beckman Coulter Renal Biomarkers Products, Services and Solutions

7.3.4 Beckman Coulter Renal Biomarkers Revenue (US$ Million) & (2019-2024)

7.3.5 Siemens Healthcare Diagnostics Recent Developments

7.4 Siemens Healthcare Diagnostics

7.4.1 Siemens Healthcare Diagnostics Profile

7.4.2 Siemens Healthcare Diagnostics Main Business

7.4.3 Siemens Healthcare Diagnostics Renal Biomarkers Products, Services and Solutions

7.4.4 Siemens Healthcare Diagnostics Renal Biomarkers Revenue (US$ Million) & (2019-2024)

7.4.5 Siemens Healthcare Diagnostics Recent Developments

7.5 Thermo Fisher Scientific

7.5.1 Thermo Fisher Scientific Profile

7.5.2 Thermo Fisher Scientific Main Business

7.5.3 Thermo Fisher Scientific Renal Biomarkers Products, Services and Solutions

7.5.4 Thermo Fisher Scientific Renal Biomarkers Revenue (US$ Million) & (2019-2024)

7.5.5 Thermo Fisher Scientific Recent Developments

7.6 Astute Medical

7.6.1 Astute Medical Profile

7.6.2 Astute Medical Main Business

7.6.3 Astute Medical Renal Biomarkers Products, Services and Solutions

7.6.4 Astute Medical Renal Biomarkers Revenue (US$ Million) & (2019-2024)

7.6.5 Astute Medical Recent Developments

7.7 BioMerieux SA

7.7.1 BioMerieux SA Profile

7.7.2 BioMerieux SA Main Business

7.7.3 BioMerieux SA Renal Biomarkers Products, Services and Solutions

7.7.4 BioMerieux SA Renal Biomarkers Revenue (US$ Million) & (2019-2024)

7.7.5 BioMerieux SA Recent Developments

7.8 Randox Laboratories

7.8.1 Randox Laboratories Profile

7.8.2 Randox Laboratories Main Business

7.8.3 Randox Laboratories Renal Biomarkers Products, Services and Solutions

7.8.4 Randox Laboratories Renal Biomarkers Revenue (US$ Million) & (2019-2024)

7.8.5 Randox Laboratories Recent Developments

7.9 Diagnostics A/S

7.9.1 Diagnostics A/S Profile

7.9.2 Diagnostics A/S Main Business

7.9.3 Diagnostics A/S Renal Biomarkers Products, Services and Solutions

7.9.4 Diagnostics A/S Renal Biomarkers Revenue (US$ Million) & (2019-2024)

7.9.5 Diagnostics A/S Recent Developments

7.10 Sphingo Tec GmbH

7.10.1 Sphingo Tec GmbH Profile

7.10.2 Sphingo Tec GmbH Main Business

7.10.3 Sphingo Tec GmbH Renal Biomarkers Products, Services and Solutions

7.10.4 Sphingo Tec GmbH Renal Biomarkers Revenue (US$ Million) & (2019-2024)

7.10.5 Sphingo Tec GmbH Recent Developments

7.11 Eli Lilly and Company

7.11.1 Eli Lilly and Company Profile

7.11.2 Eli Lilly and Company Main Business

7.11.3 Eli Lilly and Company Renal Biomarkers Products, Services and Solutions

7.11.4 Eli Lilly and Company Renal Biomarkers Revenue (US$ Million) & (2019-2024)

7.11.5 Eli Lilly and Company Recent Developments

7.12 Novartis AG

7.12.1 Novartis AG Profile

7.12.2 Novartis AG Main Business

7.12.3 Novartis AG Renal Biomarkers Products, Services and Solutions

7.12.4 Novartis AG Renal Biomarkers Revenue (US$ Million) & (2019-2024)

7.12.5 Novartis AG Recent Developments

7.13 Gentian Diagnostic

7.13.1 Gentian Diagnostic Profile

7.13.2 Gentian Diagnostic Main Business

7.13.3 Gentian Diagnostic Renal Biomarkers Products, Services and Solutions

7.13.4 Gentian Diagnostic Renal Biomarkers Revenue (US$ Million) & (2019-2024)

7.13.5 Gentian Diagnostic Recent Developments

7.14 Proteomics International

7.14.1 Proteomics International Profile

7.14.2 Proteomics International Main Business

7.14.3 Proteomics International Renal Biomarkers Products, Services and Solutions

7.14.4 Proteomics International Renal Biomarkers Revenue (US$ Million) & (2019-2024)

7.14.5 Proteomics International Recent Developments

7.15 BioPorto

7.15.1 BioPorto Profile

7.15.2 BioPorto Main Business

7.15.3 BioPorto Renal Biomarkers Products, Services and Solutions

7.15.4 BioPorto Renal Biomarkers Revenue (US$ Million) & (2019-2024)

7.15.5 BioPorto Recent Developments

8 Industry Chain Analysis

8.1 Renal Biomarkers Industrial Chain

8.2 Renal Biomarkers Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Renal Biomarkers Sales Model

8.5.2 Sales Channel

8.5.3 Renal Biomarkers Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Abbott Diagnostics

F.Hoffmann-La Roche

Beckman Coulter

Siemens HealthCare Diagnostics

Thermo Fisher Scientific

Astute Medical

BioMerieux SA

Randox Laboratories

Eli Lilly and Company

Novartis

Proteomics International

List of Tables

Table 1. Renal Biomarkers Market Trends

Table 2. Renal Biomarkers Market Drivers & Opportunity

Table 3. Renal Biomarkers Market Challenges

Table 4. Renal Biomarkers Market Restraints

Table 5. Global Renal Biomarkers Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Renal Biomarkers Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Renal Biomarkers Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Renal Biomarkers Product Type

Table 9. Key Companies Time to Begin Mass Production of Renal Biomarkers

Table 10. Global Renal Biomarkers Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Renal Biomarkers as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Renal Biomarkers Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Renal Biomarkers Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Renal Biomarkers Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Renal Biomarkers Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global Renal Biomarkers Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global Renal Biomarkers Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Renal Biomarkers Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Renal Biomarkers Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Renal Biomarkers Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global Renal Biomarkers Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global Renal Biomarkers Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global Renal Biomarkers Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Renal Biomarkers Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Renal Biomarkers Sales Value by Region (2019-2024) & (%)

Table 27. Global Renal Biomarkers Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Renal Biomarkers Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Renal Biomarkers Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Renal Biomarkers Sales Value, (2025-2030) & (US$ Million)

Table 31. Abbott Diagnostics Basic Information List

Table 32. Abbott Diagnostics Description and Business Overview

Table 33. Abbott Diagnostics Renal Biomarkers Products, Services and Solutions

Table 34. Revenue (US$ Million) in Renal Biomarkers Business of Abbott Diagnostics (2019-2024)

Table 35. Abbott Diagnostics Recent Developments

Table 36. F. Hoffmann-La Roche Basic Information List

Table 37. F. Hoffmann-La Roche Description and Business Overview

Table 38. F. Hoffmann-La Roche Renal Biomarkers Products, Services and Solutions

Table 39. Revenue (US$ Million) in Renal Biomarkers Business of F. Hoffmann-La Roche (2019-2024)

Table 40. F. Hoffmann-La Roche Recent Developments

Table 41. Beckman Coulter Basic Information List

Table 42. Beckman Coulter Description and Business Overview

Table 43. Beckman Coulter Renal Biomarkers Products, Services and Solutions

Table 44. Revenue (US$ Million) in Renal Biomarkers Business of Beckman Coulter (2019-2024)

Table 45. Beckman Coulter Recent Developments

Table 46. Siemens Healthcare Diagnostics Basic Information List

Table 47. Siemens Healthcare Diagnostics Description and Business Overview

Table 48. Siemens Healthcare Diagnostics Renal Biomarkers Products, Services and Solutions

Table 49. Revenue (US$ Million) in Renal Biomarkers Business of Siemens Healthcare Diagnostics (2019-2024)

Table 50. Siemens Healthcare Diagnostics Recent Developments

Table 51. Thermo Fisher Scientific Basic Information List

Table 52. Thermo Fisher Scientific Description and Business Overview

Table 53. Thermo Fisher Scientific Renal Biomarkers Products, Services and Solutions

Table 54. Revenue (US$ Million) in Renal Biomarkers Business of Thermo Fisher Scientific (2019-2024)

Table 55. Thermo Fisher Scientific Recent Developments

Table 56. Astute Medical Basic Information List

Table 57. Astute Medical Description and Business Overview

Table 58. Astute Medical Renal Biomarkers Products, Services and Solutions

Table 59. Revenue (US$ Million) in Renal Biomarkers Business of Astute Medical (2019-2024)

Table 60. Astute Medical Recent Developments

Table 61. BioMerieux SA Basic Information List

Table 62. BioMerieux SA Description and Business Overview

Table 63. BioMerieux SA Renal Biomarkers Products, Services and Solutions

Table 64. Revenue (US$ Million) in Renal Biomarkers Business of BioMerieux SA (2019-2024)

Table 65. BioMerieux SA Recent Developments

Table 66. Randox Laboratories Basic Information List

Table 67. Randox Laboratories Description and Business Overview

Table 68. Randox Laboratories Renal Biomarkers Products, Services and Solutions

Table 69. Revenue (US$ Million) in Renal Biomarkers Business of Randox Laboratories (2019-2024)

Table 70. Randox Laboratories Recent Developments

Table 71. Diagnostics A/S Basic Information List

Table 72. Diagnostics A/S Description and Business Overview

Table 73. Diagnostics A/S Renal Biomarkers Products, Services and Solutions

Table 74. Revenue (US$ Million) in Renal Biomarkers Business of Diagnostics A/S (2019-2024)

Table 75. Diagnostics A/S Recent Developments

Table 76. Sphingo Tec GmbH Basic Information List

Table 77. Sphingo Tec GmbH Description and Business Overview

Table 78. Sphingo Tec GmbH Renal Biomarkers Products, Services and Solutions

Table 79. Revenue (US$ Million) in Renal Biomarkers Business of Sphingo Tec GmbH (2019-2024)

Table 80. Sphingo Tec GmbH Recent Developments

Table 81. Eli Lilly and Company Basic Information List

Table 82. Eli Lilly and Company Description and Business Overview

Table 83. Eli Lilly and Company Renal Biomarkers Products, Services and Solutions

Table 84. Revenue (US$ Million) in Renal Biomarkers Business of Eli Lilly and Company (2019-2024)

Table 85. Eli Lilly and Company Recent Developments

Table 86. Novartis AG Basic Information List

Table 87. Novartis AG Description and Business Overview

Table 88. Novartis AG Renal Biomarkers Products, Services and Solutions

Table 89. Revenue (US$ Million) in Renal Biomarkers Business of Novartis AG (2019-2024)

Table 90. Novartis AG Recent Developments

Table 91. Gentian Diagnostic Basic Information List

Table 92. Gentian Diagnostic Description and Business Overview

Table 93. Gentian Diagnostic Renal Biomarkers Products, Services and Solutions

Table 94. Revenue (US$ Million) in Renal Biomarkers Business of Gentian Diagnostic (2019-2024)

Table 95. Gentian Diagnostic Recent Developments

Table 96. Proteomics International Basic Information List

Table 97. Proteomics International Description and Business Overview

Table 98. Proteomics International Renal Biomarkers Products, Services and Solutions

Table 99. Revenue (US$ Million) in Renal Biomarkers Business of Proteomics International (2019-2024)

Table 100. Proteomics International Recent Developments

Table 101. BioPorto Basic Information List

Table 102. BioPorto Description and Business Overview

Table 103. BioPorto Renal Biomarkers Products, Services and Solutions

Table 104. Revenue (US$ Million) in Renal Biomarkers Business of BioPorto (2019-2024)

Table 105. BioPorto Recent Developments

Table 106. Key Raw Materials Lists

Table 107. Raw Materials Key Suppliers Lists

Table 108. Renal Biomarkers Downstream Customers

Table 109. Renal Biomarkers Distributors List

Table 110. Research Programs/Design for This Report

Table 111. Key Data Information from Secondary Sources

Table 112. Key Data Information from Primary Sources

Table 113. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Renal Biomarkers Product Picture

Figure 2. Global Renal Biomarkers Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Renal Biomarkers Sales Value (2019-2030) & (US$ Million)

Figure 4. Renal Biomarkers Report Years Considered

Figure 5. Global Renal Biomarkers Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Renal Biomarkers Revenue in 2023

Figure 7. Renal Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. Enzyme Linked Immunosorbent Assay (ELISA) Picture

Figure 9. Enzymatic Assay Picture

Figure 10. Turbidimetric Immunoassay Picture

Figure 11. Others Picture

Figure 12. Global Renal Biomarkers Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 13. Global Renal Biomarkers Sales Value Market Share by Type, 2023 & 2030

Figure 14. Product Picture of Diagnosis and Disease Progression Monitoring

Figure 15. Product Picture of Research

Figure 16. Product Picture of Others

Figure 17. Global Renal Biomarkers Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 18. Global Renal Biomarkers Sales Value Market Share by Application, 2023 & 2030

Figure 19. North America Renal Biomarkers Sales Value (2019-2030) & (US$ Million)

Figure 20. North America Renal Biomarkers Sales Value by Country (%), 2023 VS 2030

Figure 21. Europe Renal Biomarkers Sales Value (2019-2030) & (US$ Million)

Figure 22. Europe Renal Biomarkers Sales Value by Country (%), 2023 VS 2030

Figure 23. Asia Pacific Renal Biomarkers Sales Value (2019-2030) & (US$ Million)

Figure 24. Asia Pacific Renal Biomarkers Sales Value by Country (%), 2023 VS 2030

Figure 25. South America Renal Biomarkers Sales Value (2019-2030) & (US$ Million)

Figure 26. South America Renal Biomarkers Sales Value by Country (%), 2023 VS 2030

Figure 27. Middle East & Africa Renal Biomarkers Sales Value (2019-2030) & (US$ Million)

Figure 28. Middle East & Africa Renal Biomarkers Sales Value by Country (%), 2023 VS 2030

Figure 29. Key Countries/Regions Renal Biomarkers Sales Value (%), (2019-2030)

Figure 30. United States Renal Biomarkers Sales Value, (2019-2030) & (US$ Million)

Figure 31. United States Renal Biomarkers Sales Value by Type (%), 2023 VS 2030

Figure 32. United States Renal Biomarkers Sales Value by Application (%), 2023 VS 2030

Figure 33. Europe Renal Biomarkers Sales Value, (2019-2030) & (US$ Million)

Figure 34. Europe Renal Biomarkers Sales Value by Type (%), 2023 VS 2030

Figure 35. Europe Renal Biomarkers Sales Value by Application (%), 2023 VS 2030

Figure 36. China Renal Biomarkers Sales Value, (2019-2030) & (US$ Million)

Figure 37. China Renal Biomarkers Sales Value by Type (%), 2023 VS 2030

Figure 38. China Renal Biomarkers Sales Value by Application (%), 2023 VS 2030

Figure 39. Japan Renal Biomarkers Sales Value, (2019-2030) & (US$ Million)

Figure 40. Japan Renal Biomarkers Sales Value by Type (%), 2023 VS 2030

Figure 41. Japan Renal Biomarkers Sales Value by Application (%), 2023 VS 2030

Figure 42. South Korea Renal Biomarkers Sales Value, (2019-2030) & (US$ Million)

Figure 43. South Korea Renal Biomarkers Sales Value by Type (%), 2023 VS 2030

Figure 44. South Korea Renal Biomarkers Sales Value by Application (%), 2023 VS 2030

Figure 45. Southeast Asia Renal Biomarkers Sales Value, (2019-2030) & (US$ Million)

Figure 46. Southeast Asia Renal Biomarkers Sales Value by Type (%), 2023 VS 2030

Figure 47. Southeast Asia Renal Biomarkers Sales Value by Application (%), 2023 VS 2030

Figure 48. India Renal Biomarkers Sales Value, (2019-2030) & (US$ Million)

Figure 49. India Renal Biomarkers Sales Value by Type (%), 2023 VS 2030

Figure 50. India Renal Biomarkers Sales Value by Application (%), 2023 VS 2030

Figure 51. Renal Biomarkers Industrial Chain

Figure 52. Renal Biomarkers Manufacturing Cost Structure

Figure 53. Channels of Distribution (Direct Sales, and Distribution)

Figure 54. Bottom-up and Top-down Approaches for This Report

Figure 55. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions